Article
Lenvatinib expands its reach into renal cell carcinoma
- Author:
- Edited by Jame Abraham
- MD; report prepared by Jane de Lartigue
- PhD
The US Food and Drug Administration (FDA) expanded the approval of the multitargeted tyrosine kinase inhibitor lenvatinib to a second indication...